West Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . West Pharmaceutical Services
WST Stock  USD 325.68  2.36  0.73%   
West Pharmaceutical financial statements provide useful quarterly and yearly information to potential West Pharmaceutical Services investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on West Pharmaceutical financial statements helps investors assess West Pharmaceutical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting West Pharmaceutical's valuation are summarized below:
Gross Profit
1.1 B
Profit Margin
0.1737
Market Capitalization
23.6 B
Enterprise Value Revenue
8.1353
Revenue
2.9 B
There are currently one hundred twenty fundamental gauges for West Pharmaceutical that can be evaluated and compared over time across peers. All traders should confirm West Pharmaceutical's prevalent fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 236.5 M in 2024. Enterprise Value is likely to drop to about 252.4 M in 2024

West Pharmaceutical Total Revenue

3.1 Billion

Check West Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among West Pharmaceutical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 144.2 M, Total Revenue of 3.1 B or Gross Profit of 1.2 B, as well as many indicators such as Price To Sales Ratio of 9.31, Dividend Yield of 0.0021 or PTB Ratio of 9.54. West financial statements analysis is a perfect complement when working with West Pharmaceutical Valuation or Volatility modules.
  
Check out the analysis of West Pharmaceutical Correlation against competitors.

West Pharmaceutical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4 B3.8 B2.2 B
Slightly volatile
Short and Long Term Debt Total230.5 M309 M290.8 M
Very volatile
Other Current Liabilities196.7 M187.3 M113.2 M
Slightly volatile
Total Current Liabilities705.4 M671.8 M364.3 M
Slightly volatile
Total Stockholder Equity3 B2.9 B1.5 B
Slightly volatile
Property Plant And Equipment Net1.6 B1.5 B891 M
Slightly volatile
Retained Earnings3.7 B3.5 B1.6 B
Slightly volatile
Cash896.6 M853.9 M417.4 M
Slightly volatile
Non Current Assets Total2 B1.9 B1.2 B
Slightly volatile
Non Currrent Assets Other32 M21.3 M29 M
Slightly volatile
Cash And Short Term Investments896.6 M853.9 M418.7 M
Slightly volatile
Net Receivables537.6 M512 M292.3 M
Slightly volatile
Common Stock Shares Outstanding74.7 M75.3 M73.8 M
Slightly volatile
Liabilities And Stockholders Equity4 B3.8 B2.1 B
Slightly volatile
Non Current Liabilities Total307.8 M276.7 M377.9 M
Very volatile
Inventory456.4 M434.7 M249.8 M
Slightly volatile
Other Current Assets142.6 M135.8 M64.1 M
Slightly volatile
Total Liabilities995.9 M948.5 M614.9 M
Slightly volatile
Total Current Assets2 B1.9 B1 B
Slightly volatile
Short Term Debt177.9 M169.4 M51.3 M
Slightly volatile
Intangible Assets14.3 M15.1 M29.1 M
Slightly volatile
Accounts Payable254.5 M242.4 M149.7 M
Slightly volatile
Property Plant And Equipment Gross3 B2.8 B1.2 B
Slightly volatile
Common Stock Total Equity13 M21.6 M16.1 M
Slightly volatile
Common Stock13.3 M21.6 M16.1 M
Slightly volatile
Other Liabilities107.9 M130.2 M120.7 M
Pretty Stable
Long Term Debt69.2 M72.8 M231.2 M
Slightly volatile
Good Will103.1 M108.5 M104.5 M
Slightly volatile
Property Plant Equipment1.4 B1.3 B854.7 M
Slightly volatile
Current Deferred Revenue38.2 M41.7 M40.3 M
Very volatile
Net Tangible Assets3.1 B2.9 B1.4 B
Slightly volatile
Long Term Debt Total209.4 M186 M258.9 M
Slightly volatile
Capital Surpluse223.1 M267 M208.8 M
Slightly volatile
Long Term Investments133.7 M210 M118.3 M
Slightly volatile
Non Current Liabilities Other102.4 M58.5 M128.5 M
Slightly volatile
Deferred Long Term Asset Charges12 M12.6 M43 M
Slightly volatile
Short and Long Term Debt140.7 M134 M35.9 M
Slightly volatile
Cash And Equivalents548.1 M1 B418.8 M
Slightly volatile
Net Invested Capital2.4 B3.1 B1.9 B
Slightly volatile
Net Working Capital1 B1.3 B716 M
Slightly volatile
Capital Stock15 M16.9 M18.4 M
Slightly volatile
Capital Lease Obligations93.7 M102.2 M77.8 M
Slightly volatile

West Pharmaceutical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization144.2 M137.3 M97.2 M
Slightly volatile
Total Revenue3.1 B2.9 B1.8 B
Slightly volatile
Gross Profit1.2 B1.1 B645.8 M
Slightly volatile
Other Operating Expenses2.4 B2.3 B1.5 B
Slightly volatile
Operating Income709.8 M676 M332.2 M
Slightly volatile
EBIT742.1 M706.8 M325.6 M
Slightly volatile
EBITDA886.3 M844.1 M422.9 M
Slightly volatile
Cost Of Revenue1.9 B1.8 B1.2 B
Slightly volatile
Total Operating Expenses476.7 M454 M307.2 M
Slightly volatile
Income Before Tax732.9 M698 M324.3 M
Slightly volatile
Net Income623.1 M593.4 M270.6 M
Slightly volatile
Income Tax Expense128.4 M122.3 M64.1 M
Slightly volatile
Selling General Administrative194.7 M353.4 M250 M
Slightly volatile
Research Development71.8 M68.4 M43 M
Slightly volatile
Net Income Applicable To Common Shares707.5 M673.8 M277.4 M
Slightly volatile
Net Income From Continuing Ops623.1 M593.4 M266.5 M
Slightly volatile
Tax Provision83 M122.3 M59.5 M
Slightly volatile
Interest Income29.4 M28 M10.5 M
Pretty Stable
Reconciled Depreciation124.7 M137.3 M106.4 M
Slightly volatile

West Pharmaceutical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.2 M23.3 M20 M
Slightly volatile
Free Cash Flow435.2 M414.5 M189.2 M
Slightly volatile
Begin Period Cash Flow939 M894.3 M370.4 M
Slightly volatile
Depreciation144.2 M137.3 M97.8 M
Slightly volatile
Dividends Paid59.9 M57 M38.2 M
Slightly volatile
Capital Expenditures380.1 M362 M176.6 M
Slightly volatile
Total Cash From Operating Activities815.3 M776.5 M365.8 M
Slightly volatile
Net Income623.1 M593.4 M271 M
Slightly volatile
End Period Cash Flow896.6 M853.9 M416.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.318.86935.1419
Slightly volatile
Dividend Yield0.00210.00220.0069
Slightly volatile
PTB Ratio9.549.08116.2037
Slightly volatile
Days Sales Outstanding42.7463.353454.1802
Slightly volatile
Book Value Per Share40.7138.775221.9083
Slightly volatile
Free Cash Flow Yield0.02510.01580.0202
Slightly volatile
Operating Cash Flow Per Share10.9710.45094.9917
Slightly volatile
Stock Based Compensation To Revenue0.0090.00790.0116
Very volatile
Capex To Depreciation2.772.63661.741
Slightly volatile
PB Ratio9.549.08116.2037
Slightly volatile
EV To Sales9.128.68455.1216
Slightly volatile
Free Cash Flow Per Share5.865.57872.5687
Slightly volatile
ROIC0.190.17950.1311
Slightly volatile
Inventory Turnover6.44.18825.1081
Slightly volatile
Net Income Per Share8.397.98653.6783
Slightly volatile
Days Of Inventory On Hand51.8987.150172.1003
Slightly volatile
Payables Turnover11.897.51078.7205
Slightly volatile
Sales General And Administrative To Revenue0.180.15310.1634
Pretty Stable
Research And Ddevelopement To Revenue0.01790.02320.0227
Slightly volatile
Capex To Revenue0.110.12270.094
Very volatile
Cash Per Share12.0711.49265.7006
Slightly volatile
POCF Ratio35.3833.692926.1449
Slightly volatile
Interest Coverage78.8775.111141.9174
Slightly volatile
Payout Ratio0.09130.09610.2039
Slightly volatile
Capex To Operating Cash Flow0.770.46620.573
Slightly volatile
PFCF Ratio66.2763.118358.59
Slightly volatile
Days Payables Outstanding28.5248.597242.9539
Slightly volatile
Income Quality1.241.30861.598
Slightly volatile
ROE0.220.2060.1576
Slightly volatile
EV To Operating Cash Flow34.6432.991126.2387
Slightly volatile
PE Ratio23.1844.089236.1438
Slightly volatile
Return On Tangible Assets0.170.16010.1124
Slightly volatile
EV To Free Cash Flow64.8961.803759.5923
Pretty Stable
Earnings Yield0.02150.02270.0314
Slightly volatile
Intangibles To Total Assets0.03070.03230.0667
Slightly volatile
Current Ratio1.832.88242.7123
Pretty Stable
Tangible Book Value Per Share38.9737.111720.1019
Slightly volatile
Receivables Turnover7.685.76136.8386
Slightly volatile
Graham Number87.6583.473440.7569
Slightly volatile
Shareholders Equity Per Share40.7138.775220.5229
Slightly volatile
Debt To Equity0.0740.07790.2378
Slightly volatile
Capex Per Share5.124.87212.4237
Slightly volatile
Revenue Per Share41.6939.701225.0739
Slightly volatile
Interest Debt Per Share2.423.14273.694
Slightly volatile
Debt To Assets0.05570.05860.1407
Slightly volatile
Enterprise Value Over EBITDA31.8730.34921.3884
Slightly volatile
Short Term Coverage Ratios4.865.118727.2183
Very volatile
Price Earnings Ratio23.1844.089236.1438
Slightly volatile
Operating Cycle94.62151126
Slightly volatile
Price Book Value Ratio9.549.08116.2037
Slightly volatile
Days Of Payables Outstanding28.5248.597242.9539
Slightly volatile
Dividend Payout Ratio0.09130.09610.2039
Slightly volatile
Price To Operating Cash Flows Ratio35.3833.692926.1449
Slightly volatile
Price To Free Cash Flows Ratio66.2763.118358.59
Slightly volatile
Pretax Profit Margin0.250.23660.1562
Slightly volatile
Ebt Per Ebit0.981.03250.954
Slightly volatile
Operating Profit Margin0.240.22920.1609
Slightly volatile
Effective Tax Rate0.290.17520.2484
Slightly volatile
Company Equity Multiplier2.121.32921.6245
Slightly volatile
Long Term Debt To Capitalization0.02340.02460.1625
Slightly volatile
Total Debt To Capitalization0.06870.07230.1803
Slightly volatile
Return On Capital Employed0.220.21410.1609
Slightly volatile
Debt Equity Ratio0.0740.07790.2378
Slightly volatile
Ebit Per Revenue0.240.22920.1609
Slightly volatile
Quick Ratio1.282.23531.969
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.031.85321.5305
Slightly volatile
Net Income Per E B T0.580.85010.7765
Pretty Stable
Cash Ratio1.331.27111.0243
Slightly volatile
Cash Conversion Cycle94.9110287.1655
Slightly volatile
Operating Cash Flow Sales Ratio0.280.26320.1824
Slightly volatile
Days Of Inventory Outstanding51.8987.150172.1003
Slightly volatile
Days Of Sales Outstanding42.7463.353454.1802
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.560.53380.449
Slightly volatile
Cash Flow Coverage Ratios3.633.45881.5249
Slightly volatile
Price To Book Ratio9.549.08116.2037
Slightly volatile
Fixed Asset Turnover1.581.95032.0069
Pretty Stable
Capital Expenditure Coverage Ratio1.262.1451.9072
Slightly volatile
Price Cash Flow Ratio35.3833.692926.1449
Slightly volatile
Enterprise Value Multiple31.8730.34921.3884
Slightly volatile
Debt Ratio0.05570.05860.1407
Slightly volatile
Cash Flow To Debt Ratio3.633.45881.5249
Slightly volatile
Price Sales Ratio9.318.86935.1419
Slightly volatile
Return On Assets0.160.1550.1058
Slightly volatile
Asset Turnover0.980.77030.8661
Pretty Stable
Net Profit Margin0.210.20120.1264
Slightly volatile
Gross Profit Margin0.260.38280.3323
Slightly volatile
Price Fair Value9.549.08116.2037
Slightly volatile
Return On Equity0.220.2060.1576
Slightly volatile

West Pharmaceutical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap236.5 M442.1 M451.8 M
Very volatile
Enterprise Value252.4 M374.8 M390 M
Very volatile

West Fundamental Market Drivers

Forward Price Earnings44.0529
Cash And Short Term Investments853.9 M

West Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About West Pharmaceutical Financial Statements

West Pharmaceutical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although West Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. The changes in West Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses on on West Pharmaceutical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue41.7 M38.2 M
Total Revenue2.9 B3.1 B
Cost Of Revenue1.8 B1.9 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.15  0.18 
Research And Ddevelopement To Revenue 0.02  0.02 
Capex To Revenue 0.12  0.11 
Revenue Per Share 39.70  41.69 
Ebit Per Revenue 0.23  0.24 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY